Skip to main content
Log in

Die Verstärkung des narkotischen Effekts und die Abbauhemmung von Hexobarbital durch Malonsäurederivate

  • Published:
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie Aims and scope Submit manuscript

Summary

The potentiating effect of three malonic acid and one succinic acid derivatives on the duration of the anesthetic action of hexobarbital has been studied on rats and mice. It has been found that these substances inhibite the catabolism of hexobarbital in liver homogenates.

Some of the compounds studied were more potent in potentiating the hexobarbital anesthesia after oral administration.

The butyl-ethyl derivative prolonged the anesthesia on female rats twelve fould and on male rats only three fould. This difference were abolished by castration of the animals. In vitro, however, castration did not have any considerable influence on the hexobarbital-oxydation blocking activity of the compounds.

Pretreatment of rats with phenobarbital produce 1. a significant reduction of the anesthetic effect of hexobarbital, due to its more rapid metabolic oxydation, and 2. a nearly complete loss of activity of the butyl-ethylmalonic acid ester to potentiate the hexobarbital effect. On the increased hexobarbital oxydation in liver homogenates from phenobarbital pretreated rats, the phenyl-ethyl- and the butyl-ethyl malonic acid derivatives do not have any blocking activity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Literatur

  • Axelrod. J., J. Reichenthal and B. B. Brodie: Mechanism of the potentiating action of β-diethylaminoethyl diphenylpropyl acetate. J. Pharmacol. exp. Ther. 112, 49 (1954).

    Google Scholar 

  • Brodie. B. B., J. J. Burne, L. C. Marck, P. A. Lief, E. Bernstein and E. M. Papper: The fate of pentobarbital in man and dog and a method for its estimation in biological material. J. Pharmacol. exp. Ther. 109, 26 (1953).

    Google Scholar 

  • Cavallini. G., E. Milla, E. Grumelli, F. Ravenna e I. Grasso: Sopra alcuni piridin e piperidin derivati del difenilmetano 4-cloro sostituiti e loro proprietà farmacologica. Farmaco, Ed. sci. 12, 853 (1957).

    Google Scholar 

  • Conney. A. H., E. C. Miller and J. A. Miller: Substrate-induced synthesis and other properties of benzpyrene hydroxylase in rat liver. J. biol. Chem. 228, 753 (1957).

    Google Scholar 

  • Cook. L., E. Macko and E. J. Fellows: The effect of β-diethylaminoethyl diphenylpropyl acetate hydrochloride on the action of a series of barbiturates and C.N.S. depressants. J. Pharmacol. exp. Ther. 111, 382 (1954).

    Google Scholar 

  • Cook. L., J. Toner and E. J. Fellows: The effect of β-diethylaminoethyldiphenylpropyl acetate hydrochloride (SKF No. 525 A) on hexobarbital. J. Pharmacol. exp. Ther. 111, 131 (1954).

    Google Scholar 

  • Cooper. J. B., and B. B. Brodie: The enzymatic metabolism of hexobarbital (Evipal). J. Pharmacol. Exp. Ther. 114, 409 (1955).

    Google Scholar 

  • Fouts. J. R., and B. B. Brodie: Inhibition of drug metabolic pathways by the potentiating agent 2,4-dichloro-6-phenyl-phenoxyethyl diethylamine. J. Pharmacol. exp. Ther. 115, 68 (1955).

    Google Scholar 

  • Fouts. J. R., and B. B. Brodie: On the mechanism of drug potentiation by iproniazid (2-isopropyl-1-isonicotinyl hydrazine). J. Pharmacol. exp. Ther. 116, 480 (1956).

    Google Scholar 

  • Holtz. P., H. Balzer, E. Westermann u. E. Wezler: Beeinflussung der Evipannarkose durch Reserpin, Iproniazid und biogene Amine. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 231, 333 (1957).

    Google Scholar 

  • Loewe. S.: Die quantitativen Probleme der Pharmakologie. Ergebn. Physiol. 27, 47 (1928).

    Google Scholar 

  • Loewe. S.: The problem of synergism and antagonism of combined drugs. Arzneimittel-Forsch. 3, 285 (1953).

    Google Scholar 

  • Loewe. S.: Potentiation of drug-produced ejaculation by β-diethylaminoethyldiphenylpropylacetate (SKF NO. 525 A). J. Pharmacol. exp. Ther. 110, 271 (1954).

    Google Scholar 

  • Loewe. S.: Antagonism and Antagonists. Pharmacol. Rev. 9, 237 (1957).

    Google Scholar 

  • Neubert. D., u. H. Herken: Wirkungssteigerung von Schlafmitteln durch den Phenyldiallylessigsäureester des Diäthylaminoäthanols. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 225, 453 (1955).

    Google Scholar 

  • Remmer. H.: Geschlechtsspezifische Unterschiede in der Entgiftung von Evipan und Thiopental bei Ratten. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 233, 173 (1958).

    Google Scholar 

  • Remmer. H.: Der beschleunigte Abbau von Pharmaka in den Lebermikrosomen unter Einfluß von Luminal. Naunyn-Schmiedeberg's Arch. exp. Path. Pharmak. 235, 279 (1959).

    Google Scholar 

  • Remmer. H., u. B. Alsleben: Die Aktivierung der Entgiftung in den Lebermikrosomen während der Gewöhnung. Klin. Wschr. 36, 332 (1958).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Herrn Professor Dr. W. S. Loewe, Salt Lake City, zum 75. Geburtstag gewidmet.

Mit 5 Textabbildungen

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kramer, M., Arrigoni-Martelli, E. Die Verstärkung des narkotischen Effekts und die Abbauhemmung von Hexobarbital durch Malonsäurederivate. Naunyn - Schmiedebergs Arch 237, 264–275 (1959). https://doi.org/10.1007/BF00244734

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00244734

Navigation